Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3335 Efficacy of somatostatin analogue (SSA) monotherapy for well-differentiated grade 3 (G3) gastroenteropancreatic neuroendocrine tumors (NETs)

Introduction: Currently, there is minimal published data on the efficacy of SSAs for well-differentiated G3 NETs. Randomized trials have demonstrated a progression-free survival (PFS) benefit and limited response for lower grade 1-2 NETs, but the optimal therapy for metastatic G3 NETs is unknown.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: McGarrah P

Authors: McGarrah P, Liu A, Hobday T, Starr J, Kendi A,

Keywords: somatostatin analogues, lanreotide, octreotide, well-differentiated grade 3 neuroendocrine tumor, G3net, G3nen,

#3256 Surgical outcomes in extrapulmonary G3 neuroendocrine neoplasms

Introduction: Incidence of high-grade neuroendocrine (NE) neoplasms (G3NENs) is increasing. Heterogeneity of these tumors (well-differentiated NE tumors, G3NETs; poorly differentiated NE carcinomas, NEC) presents obstacles to clinical management and role of surgery is uncertain. Majority of published data suggest benefit of surgery in NECs limited to localized disease. Role of surgery in G3NET remains ill-defined.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Lopez M

Authors: Lopez M, Whitman J, Le B, Paciorek A, Zhang L,

Keywords: resection, G3NET, differentiation, G3NEN,